Structures by: Sridhar B.
Total: 368
C21H19NO6
C21H19NO6
Journal of Natural Products (2019)
a=6.89532(9)Å b=12.63419(15)Å c=20.7068(2)Å
α=90° β=90° γ=90°
C23H20BrN3O3PdS,C2H4O2
C23H20BrN3O3PdS,C2H4O2
Catalysis Science & Technology (2012) 2, 6 1180
a=7.724(5)Å b=13.385(5)Å c=14.000(5)Å
α=68.935(5)° β=83.939(5)° γ=89.447(5)°
C29H26N2O5S
C29H26N2O5S
Organic Chemistry Frontiers (2016) 3, 11 1503
a=8.3151(7)Å b=8.6250(7)Å c=18.7838(16)Å
α=99.7400(10)° β=96.6860(10)° γ=104.0170(10)°
C16H16O3S
C16H16O3S
Organic Chemistry Frontiers (2016) 3, 7 795
a=5.9262(4)Å b=8.0475(5)Å c=31.957(2)Å
α=90° β=90° γ=90°
C26H31N3O7
C26H31N3O7
Organic letters (2017) 19, 1 170-173
a=8.4235(8)Å b=17.6443(17)Å c=17.7369(17)Å
α=90° β=90° γ=90°
C28H24N2O2
C28H24N2O2
Organic letters (2017) 19, 1 282-285
a=18.5420(9)Å b=8.1490(4)Å c=16.4280(10)Å
α=90° β=112.2960(10)° γ=90°
C21H26N2O2S
C21H26N2O2S
Organic letters (2015) 17, 9 2226-2229
a=7.3915(12)Å b=13.779(2)Å c=19.135(3)Å
α=90° β=93.863(3)° γ=90°
C16H14N2O2S
C16H14N2O2S
Organic letters (2015) 17, 9 2226-2229
a=11.2250(18)Å b=13.361(2)Å c=11.0143(18)Å
α=90° β=118.102(2)° γ=90°
C17H16N2O2S
C17H16N2O2S
Organic letters (2015) 17, 9 2226-2229
a=8.9148(6)Å b=16.7339(11)Å c=10.5655(7)Å
α=90° β=95.8550(10)° γ=90°
C21H22FNO4
C21H22FNO4
Organic letters (2014) 16, 24 6267-6269
a=5.848(3)Å b=12.300(6)Å c=25.729(13)Å
α=90.00° β=91.785(8)° γ=90.00°
Dimethyl 1-allyl-2'-(4-nitrophenyl)-2-oxo-3'-(p-tolyl)spiro[indoline-3,4' -oxazolidine]-5',5'-dicarboxylate
C30H27N3O8
Organic Letters (2013) 15, 7 1512
a=22.5171(11)Å b=13.1220(6)Å c=21.6558(10)Å
α=90.00° β=118.3660(10)° γ=90.00°
C32H28N2O9
C32H28N2O9
Organic Letters (2013) 15, 7 1512
a=7.9805(11)Å b=19.764(3)Å c=17.862(3)Å
α=90.00° β=99.901(2)° γ=90.00°
Ethyl 2-methyl-5-phenyl-1H-pyrrole-3-carboxylate
C14H15NO2
Organic letters (2013) 15, 3 464-467
a=11.7298(8)Å b=9.2723(6)Å c=11.8853(8)Å
α=90.00° β=103.883(1)° γ=90.00°
1-(5,6-dimethoxy-3-methyl-1H-indol-2-yl)-2-methylpropan-1-one
C15H19NO3
Organic letters (2013) 15, 3 464-467
a=6.9397(7)Å b=8.8694(10)Å c=11.1168(12)Å
α=97.572(2)° β=94.165(2)° γ=92.775(2)°
C14H25NO4
C14H25NO4
Organic letters (2012) 14, 4 1082-1085
a=9.3943(8)Å b=9.5053(8)Å c=10.3313(9)Å
α=84.8260(10)° β=72.3680(10)° γ=65.4330(10)°
C14H25NO5
C14H25NO5
Organic letters (2012) 14, 4 1082-1085
a=9.8718(7)Å b=10.0720(8)Å c=16.2663(12)Å
α=90.00° β=90.00° γ=90.00°
C16H25Cl3N2O5
C16H25Cl3N2O5
Organic letters (2012) 14, 4 1082-1085
a=11.1228(7)Å b=18.7458(11)Å c=20.9423(13)Å
α=90.00° β=90.00° γ=90.00°
C16H25Cl3N2O5
C16H25Cl3N2O5
Organic letters (2012) 14, 4 1082-1085
a=11.454(9)Å b=6.186(5)Å c=15.081(12)Å
α=90.00° β=105.582(12)° γ=90.00°
C20H24N2O4
C20H24N2O4
Organic letters (2015) 17, 15 3730-3733
a=11.5233(13)Å b=7.6374(8)Å c=11.6452(13)Å
α=90° β=110.244(2)° γ=90°
C31H22N2O3
C31H22N2O3
RSC Advances (2020) 10, 59 35681-35691
a=8.2197(2)Å b=10.4608(2)Å c=14.4752(3)Å
α=77.0948(8)° β=79.6924(8)° γ=81.5655(9)°
C34H31BrN2O3S,CHCl3
C34H31BrN2O3S,CHCl3
Organic & biomolecular chemistry (2020) 18, 34 6710-6715
a=9.5464(3)Å b=11.3522(3)Å c=16.3209(5)Å
α=79.8713(9)° β=82.8439(10)° γ=76.7777(10)°
C17H10ClNO3
C17H10ClNO3
Organic & biomolecular chemistry (2020) 18, 9 1743-1746
a=16.2453(4)Å b=8.9674(2)Å c=9.7074(2)Å
α=90° β=93.2014(10)° γ=90°
C20H19N3O
C20H19N3O
Organic & biomolecular chemistry (2018) 16, 26 4840-4848
a=19.497(5)Å b=8.597(2)Å c=19.553(4)Å
α=90° β=90° γ=90°
C19H18ClNO3S
C19H18ClNO3S
Organic & biomolecular chemistry (2018) 16, 28 5163-5166
a=15.5285(11)Å b=12.2909(9)Å c=18.3647(13)Å
α=90° β=90° γ=90°
C19H15N3O3
C19H15N3O3
Organic & biomolecular chemistry (2019) 17, 10 2809-2817
a=7.021(9)Å b=20.14(3)Å c=21.54(3)Å
α=90° β=95.79(2)° γ=90°
C17H17NO2
C17H17NO2
Organic & biomolecular chemistry (2019) 17, 18 4440-4445
a=7.21212(9)Å b=15.4816(2)Å c=26.0416(3)Å
α=90° β=90° γ=90°
C23H18FNO4
C23H18FNO4
Organic & biomolecular chemistry (2019) 17, 16 4121-4128
a=8.66220(10)Å b=10.7712(2)Å c=11.1760(2)Å
α=102.4181(5)° β=97.3598(5)° γ=113.4266(4)°
3-Iodo-6-methoxy-4-(p-methoxyphenyl)-2-trifluoromethyl)quinoline
C18H13F3INO2
Organic & Biomolecular Chemistry (2009) 7, 1 85-93
a=8.995(2)Å b=10.147(2)Å c=11.016(3)Å
α=107.100(4)° β=95.726(4)° γ=110.042(3)°
3-Iodo-4-phenyl-2-trifluoromethyl-1-aza-spiro[4.5]deca-1,3,6,9-tetraen-8-one
C16H9F3INO
Organic & Biomolecular Chemistry (2009) 7, 1 85-93
a=5.5479(6)Å b=18.4740(19)Å c=14.5807(15)Å
α=90.00° β=99.871(2)° γ=90.00°
C53H41ClF3NOP2PdS,CHCl3,CCl4
C53H41ClF3NOP2PdS,CHCl3,CCl4
Organic & biomolecular chemistry (2010) 8, 13 3001-3006
a=11.9921(15)Å b=13.0949(16)Å c=20.722(3)Å
α=72.277(2)° β=75.153(2)° γ=67.700(2)°
2-(4-Fluoro-2-(4-(trifluoromethyl)benzamido)phenyl)-6-phenyl-5,6-dihydro-4H-1,3-oxazin-5-yl acetate
C26H20F4N2O4
Organic & biomolecular chemistry (2016) 14, 42 10074-10079
a=9.7279(17)Å b=11.657(2)Å c=22.965(4)Å
α=76.436(3)° β=80.414(3)° γ=70.405(3)°
C13H13ClO3
C13H13ClO3
Organic & biomolecular chemistry (2016) 14, 37 8832-8837
a=7.1086(14)Å b=6.9376(14)Å c=12.442(3)Å
α=90° β=94.573(3)° γ=90°
(1R,3aS,6R,6aR)-1-(2-bromophenyl)-6-phenyl-hexahydrofuro[3,4-c]furan
C18H17BrO2
Organic & biomolecular chemistry (2014) 12, 26 4754-4762
a=9.6034(5)Å b=15.7805(8)Å c=19.7861(10)Å
α=90.00° β=90.00° γ=90.00°
(1R,4aS,8S,8aS)-1-(2-bromophenyl)-8-phenyl-octahydropyrano[3,4-c]pyran
C20H21BrO2
Organic & biomolecular chemistry (2014) 12, 26 4754-4762
a=11.2110(12)Å b=16.7616(18)Å c=18.3398(19)Å
α=90.00° β=90.00° γ=90.00°
(4S,5R,6S,7R)-7-methyl-3-phenyl-4,5,6,7-tetrahydro-[1,2,3]triazolo [1,5-a]pyridine-4,5,6-triol
C13H15N3O3
Organic & biomolecular chemistry (2014) 12, 42 8415-8421
a=7.0280(11)Å b=12.5922(19)Å c=14.037(2)Å
α=90.00° β=90.00° γ=90.00°
(4S,5R,6S,7R)-7-methyl-3-p-tolyl-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a] pyridine-4,5,6-triol
C14H17N3O3
Organic & biomolecular chemistry (2014) 12, 42 8415-8421
a=7.5550(5)Å b=11.9870(8)Å c=15.0918(11)Å
α=90.00° β=90.00° γ=90.00°
C26H20N2O5
C26H20N2O5
Organic & biomolecular chemistry (2015) 13, 5 1347-1357
a=7.1637(7)Å b=26.057(3)Å c=11.5507(11)Å
α=90.00° β=95.513(2)° γ=90.00°
C29H25NO4
C29H25NO4
Organic & biomolecular chemistry (2015) 13, 10 3011-3023
a=8.1432(16)Å b=15.506(3)Å c=19.315(4)Å
α=90.00° β=99.992(3)° γ=90.00°
C20H18Cl2O2
C20H18Cl2O2
Organic & biomolecular chemistry (2015) 13, 16 4733-4736
a=11.7351(14)Å b=10.1832(12)Å c=14.5872(18)Å
α=90° β=99.078(2)° γ=90°
C17H19NO5
C17H19NO5
Organic & biomolecular chemistry (2016) 14, 1 288-295
a=13.6571(12)Å b=7.7611(7)Å c=14.9680(14)Å
α=90° β=91.630(2)° γ=90°
C17H14INO2
C17H14INO2
Organic & biomolecular chemistry (2016) 14, 1 288-295
a=13.7811(12)Å b=13.3475(11)Å c=16.9711(15)Å
α=90° β=90° γ=90°
C25H25N2O6P
C25H25N2O6P
Organic & biomolecular chemistry (2014) 12, 10 1595-1602
a=8.901(2)Å b=12.206(3)Å c=22.343(6)Å
α=90.00° β=90.00° γ=90.00°
C18H13FO4
C18H13FO4
Organic & biomolecular chemistry (2016) 14, 14 3526-3535
a=8.1761(5)Å b=11.9692(7)Å c=15.1398(9)Å
α=90° β=96.3430(10)° γ=90°
C18H23NO3
C18H23NO3
Organic & biomolecular chemistry (2015) 13, 32 8729-8733
a=24.909(2)Å b=9.2315(8)Å c=6.9138(6)Å
α=90° β=90° γ=90°
C23H22O2
C23H22O2
Organic & biomolecular chemistry (2016) 14, 12 3234-3237
a=28.1542(16)Å b=8.5012(5)Å c=17.4613(10)Å
α=90° β=122.609(1)° γ=90°
(4R,4aR,10bS)-4-(4-methoxyphenyl)-2,4,4a,5,6,10b-hexahydro-1H- benzo[f]isochromene
C20H22O2
Organic & biomolecular chemistry (2012) 10, 7 1349-1358
a=18.554(4)Å b=6.2560(15)Å c=13.851(3)Å
α=90.00° β=100.778(4)° γ=90.00°
(1R*,4aS*,10aS*)-1-(3,4-dimethoxyphenyl)-1,3,4,4a,10,10a-hexahydropyrano [4,3-b]chromene
C20H22O4
Organic & biomolecular chemistry (2012) 10, 32 6562-6568
a=12.8286(7)Å b=12.1802(7)Å c=11.4263(6)Å
α=90.00° β=111.313(1)° γ=90.00°
C19H20O2
C19H20O2
Organic & biomolecular chemistry (2015) 13, 24 6737-6741
a=8.6637(7)Å b=15.5478(12)Å c=11.0472(9)Å
α=90° β=90° γ=90°
C20H19BrClO3
C20H19BrClO3
Organic & biomolecular chemistry (2016) 14, 4 1332-1337
a=8.241(3)Å b=9.598(4)Å c=25.276(10)Å
α=90° β=99.148(6)° γ=90°
C35H25ClF6N2O2PtS2
C35H25ClF6N2O2PtS2
Organic & biomolecular chemistry (2016) 14, 4 1382-1394
a=13.4868(14)Å b=15.2064(16)Å c=17.7733(19)Å
α=90.00° β=107.750(2)° γ=90.00°
C21H17FeNO3S
C21H17FeNO3S
New Journal of Chemistry (2018) 42, 15 12587
a=6.78250(10)Å b=12.1423(2)Å c=22.2710(4)Å
α=90° β=90° γ=90°
C21H16N2O4
C21H16N2O4
New Journal of Chemistry (2018) 42, 16 13819
a=9.965(8)Å b=8.009(6)Å c=21.306(16)Å
α=90° β=90.73(2)° γ=90°
C21H20FeN4O
C21H20FeN4O
New Journal of Chemistry (2019) 43, 21 8341
a=18.8546(2)Å b=9.66650(10)Å c=10.3076(3)Å
α=90° β=93.9343(6)° γ=90°
C22H28NO3,C6H2N3O7
C22H28NO3,C6H2N3O7
New Journal of Chemistry (2019) 43, 27 11003
a=22.0277(12)Å b=13.4965(7)Å c=21.8512(12)Å
α=90° β=118.2720(10)° γ=90°
C27H23NO
C27H23NO
New J. Chem. (2016) 40, 7 6389
a=11.3302(8)Å b=10.5415(7)Å c=16.9754(12)Å
α=90° β=95.253(1)° γ=90°
C19H16FeO
C19H16FeO
New Journal of Chemistry (2014) 38, 1 227
a=17.913(2)Å b=9.5455(12)Å c=8.8695(11)Å
α=90.00° β=99.613(2)° γ=90.00°
1-(2-(dimethylamino)-5-iso-propylphenyl) dibenzo[b,d]furan-2-ol
C23H23NO2
RSC Advances (2013) 3, 37 16475
a=7.8847(5)Å b=11.3771(7)Å c=20.8098(13)Å
α=90.00° β=90.00° γ=90.00°
5-(5-oxo-5,6,7,8-tetrahydroquinolin-2-yl)thiophen-2-yl acetate
C15H13NO3S
RSC Advances (2013) 3, 26 10251
a=12.5933(11)Å b=15.1264(13)Å c=15.0649(13)Å
α=90.00° β=111.798(1)° γ=90.00°
C25H23NO3
C25H23NO3
RSC Advances (2013) 3, 26 10251
a=16.2313(10)Å b=15.4503(10)Å c=8.0772(5)Å
α=90.00° β=96.738(1)° γ=90.00°
C9H7N5O2
C9H7N5O2
RSC Advances (2013) 3, 21 7708
a=9.8335(7)Å b=8.2851(6)Å c=12.1849(8)Å
α=90.00° β=102.006(0)° γ=90.00°
C15H12N6O
C15H12N6O
RSC Advances (2013) 3, 21 7708
a=12.6583(8)Å b=7.1048(4)Å c=15.7542(10)Å
α=90.00° β=104.404(1)° γ=90.00°
C18H17NO3
C18H17NO3
RSC Advances (2012) 2, 28 10661
a=18.360(3)Å b=10.7617(18)Å c=15.277(3)Å
α=90.00° β=90.00° γ=90.00°
Cytosinium-3,5-dinitrobenzoate trihydrate
C4H6N3O,C7H3N2O6,3(H2O)
CrystEngComm (2012) 14, 20 7065
a=5.0257(3)Å b=24.5327(15)Å c=13.1664(8)Å
α=90.00° β=90.462(1)° γ=90.00°
Cytosinium para amino benzoate cytosine monohydrate
C4H6N3O,C7H6NO2,C4H5N3O,H2O
CrystEngComm (2012) 14, 20 7065
a=7.3666(3)Å b=6.4615(3)Å c=36.9629(16)Å
α=90.00° β=94.462(1)° γ=90.00°
Cytosinium 4-hydroxyphenylacetate cytosine monohydrate
C4H6N3O,C8H7O3,C4H5N3O,H2O
CrystEngComm (2012) 14, 20 7065
a=14.9164(10)Å b=12.3456(8)Å c=19.9754(13)Å
α=90.00° β=90.00° γ=90.00°
Cytosinium-2,5-dihydroxybenzoate
C4H6N3O,C7H5O4
CrystEngComm (2012) 14, 20 7065
a=10.1137(8)Å b=8.5120(7)Å c=13.9992(12)Å
α=90.00° β=110.610(1)° γ=90.00°
C24H26N6
C24H26N6
RSC Advances (2016) 6, 49 43638
a=7.619(2)Å b=9.692(3)Å c=15.884(5)Å
α=75.952(5)° β=79.091(5)° γ=71.433(5)°
C20H21IN2O4S
C20H21IN2O4S
Chem.Commun. (2014) 50, 8526
a=8.0734(5)Å b=17.0233(10)Å c=15.3571(9)Å
α=90.00° β=96.854(1)° γ=90.00°
C24H26N2O6S,CHCl3
C24H26N2O6S,CHCl3
Chem.Commun. (2014) 50, 8526
a=17.5098(18)Å b=8.4729(9)Å c=18.956(2)Å
α=90.00° β=94.435(2)° γ=90.00°
C24H34O6
C24H34O6
Med. Chem. Commun. (2015) 6, 5 898
a=11.987(3)Å b=12.551(3)Å c=14.454(4)Å
α=90.00° β=90.00° γ=90.00°
C24H34O7
C24H34O7
Med. Chem. Commun. (2015) 6, 5 898
a=12.4798(16)Å b=12.7207(17)Å c=14.3452(19)Å
α=90.00° β=90.00° γ=90.00°
C12H11NO2
C12H11NO2
Chem.Commun. (2015) 51, 13646
a=7.7718(8)Å b=5.5207(5)Å c=11.7443(11)Å
α=90° β=91.969(2)° γ=90°
C19H17NO4
C19H17NO4
Chemical communications (Cambridge, England) (2016) 52, 25 4675-4678
a=8.9379(13)Å b=10.7203(16)Å c=11.0337(16)Å
α=118.687(2)° β=110.073(2)° γ=93.964(2)°
2,2,8,9,13,13-Hexamethyl-2a,3,10c,12,13,14-hexahydro-2H-1,4,10- trioxa-dibenzo[c,g]phenanthrene-7,11-dione
C25H28O5
MedChemComm (2012) 3, 6 652
a=11.7974(15)Å b=13.9420(18)Å c=13.4238(17)Å
α=90.00° β=101.254(2)° γ=90.00°
2,2,8,-Trimethyl-2a,3,10c,12,13,14-hexahydro-2H-1,4,10-trioxa-dibenzo[c.g] phenanthrene-7,11-dione
C22H22O5
MedChemComm (2012) 3, 6 652
a=15.4539(11)Å b=7.4613(5)Å c=16.2148(11)Å
α=90.00° β=106.214(1)° γ=90.00°
C19H18O3
C19H18O3
Chemical communications (Cambridge, England) (2008) 42 5324-5326
a=10.1848(8)Å b=17.5488(14)Å c=8.8167(7)Å
α=90.00° β=90.00° γ=90.00°
2(C38H34N4O2),C7H8
2(C38H34N4O2),C7H8
Journal of Materials Chemistry (2009) 19, 34 6172
a=11.6784(10)Å b=13.4373(11)Å c=14.2959(12)Å
α=64.349(1)° β=66.210(1)° γ=64.589(1)°
C50H58N4O2
C50H58N4O2
Journal of Materials Chemistry (2009) 19, 34 6172
a=13.4303(7)Å b=14.1082(8)Å c=14.3536(8)Å
α=107.583(1)° β=111.517(1)° γ=105.634(1)°
Dutasteride hemihydrate
2(C27H30F6N2O2),H2O
CrystEngComm (2012) 14, 7 2571
a=8.2124(7)Å b=18.5162(17)Å c=34.876(3)Å
α=90.00° β=90.00° γ=90.00°
Dutasteride chloride hydrate ethanol solvate
C27H31F6N2O2,Cl,H2O,C2H6O
CrystEngComm (2012) 14, 7 2571
a=7.9357(7)Å b=9.1050(8)Å c=11.1952(9)Å
α=73.7460(10)° β=88.6870(10)° γ=86.1930(10)°
2(C34H24N2O4),C2H5O
2(C34H24N2O4),C2H5O
RSC Advances (2020) 10, 59 35681-35691
a=9.1182(6)Å b=13.8291(10)Å c=23.4126(16)Å
α=103.5810(10)° β=91.205(2)° γ=98.758(2)°
(2-(2-Benzamidophenyl)-4,5-dihydrooxazol-5-yl)methyl acetate
C19H18N2O4
Organic & biomolecular chemistry (2016) 14, 42 10074-10079
a=7.3604(4)Å b=9.3854(6)Å c=12.8395(10)Å
α=95.461(4)° β=101.655(4)° γ=105.055(3)°
C38H22CdN8O12,C3H7NO,H2O
C38H22CdN8O12,C3H7NO,H2O
CrystEngComm (2015) 17, 21 3912
a=12.913(1)Å b=13.7018(10)Å c=14.1084(11)Å
α=114.394(1)° β=107.217(1)° γ=98.206(1)°
C28H42O8
C28H42O8
RSC Adv. (2015) 5, 113 93122
a=9.9588(6)Å b=11.4669(7)Å c=47.914(3)Å
α=90.00° β=90.00° γ=90.00°
8-bromo-13-iodo-12-phenyl-6H-isoquinolino[2,1-a]quinazolin-6-one
C22H12BrIN2O
Chem.Commun. (2013) 49, 10109
a=10.9230(8)Å b=14.4605(11)Å c=24.1159(18)Å
α=90.00° β=99.242(2)° γ=90.00°
13-iodo-8-methyl-phenyl-5-(phenylamino)-4bH-isoquinolino[2,1-a]quinazolin-6(5H) -one ethyl acetate solvate
2(C29H22IN3O),C4H8O2
Chem.Commun. (2013) 49, 10109
a=13.303(4)Å b=14.085(5)Å c=15.615(5)Å
α=78.968(6)° β=71.429(6)° γ=88.226(6)°
Moxonidine
C9H12ClN5O
CrystEngComm (2014) 16, 46 10602
a=21.293(2)Å b=7.8312(9)Å c=13.9098(16)Å
α=90.00° β=109.820(2)° γ=90.00°
Moxonidine hydrochloride monohydrate
C9H13ClN5O,Cl,H2O
CrystEngComm (2014) 16, 46 10602
a=8.5413(10)Å b=13.2793(15)Å c=24.376(3)Å
α=90.00° β=90.00° γ=90.00°
Aripiprazole hydrochloride salt
C23H28Cl2N3O2,Cl
CrystEngComm (2013) 15, 21 4321
a=10.2891(12)Å b=28.065(3)Å c=7.9247(9)Å
α=90.00° β=90.885(2)° γ=90.00°
Aripiprazole benzoate monohydrate
C23H28Cl2N3O2,C7H5O2,H2O
CrystEngComm (2013) 15, 21 4321
a=14.9688(10)Å b=9.9536(6)Å c=20.9154(14)Å
α=90.00° β=108.0040(10)° γ=90.00°
Aripiprazole-2,4-dihydoxybenzoate
C23H28Cl2N3O2,C7H5O4
CrystEngComm (2013) 15, 21 4321
a=15.1552(8)Å b=9.5732(5)Å c=21.5283(11)Å
α=90.00° β=103.8870(10)° γ=90.00°
Aripiprazole-2,5-dihydroxybenzoate hemihydrate
2(C23H28Cl2N3O2),2(C7H5O4),H2O
CrystEngComm (2013) 15, 21 4321
a=30.4165(19)Å b=9.7801(6)Å c=20.5636(13)Å
α=90.00° β=105.3190(10)° γ=90.00°
(C23H14O62),2(C4H12N5)
(C23H14O62),2(C4H12N5)
CrystEngComm (2013) 15, 22 4448
a=17.8097(8)Å b=7.9282(4)Å c=25.8018(9)Å
α=90.00° β=119.499(2)° γ=90.00°
2(C4H12N5),C23H14O62
2(C4H12N5),C23H14O62
CrystEngComm (2013) 15, 22 4448
a=7.4680(6)Å b=13.8016(11)Å c=16.2856(13)Å
α=73.334(1)° β=83.171(1)° γ=82.666(1)°
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4- dihydrocarbostyril)
C23H27Cl2N3O2
CrystEngComm (2012) 14, 14 4677
a=12.2626(7)Å b=13.7872(8)Å c=14.7405(9)Å
α=101.396(1)° β=108.921(1)° γ=98.847(1)°
C20H21BCl2N2O5Pd
C20H21BCl2N2O5Pd
Dalton transactions (Cambridge, England : 2003) (2015) 44, 40 17600-17616
a=9.8914(11)Å b=10.6681(12)Å c=22.200(2)Å
α=90.00° β=90.00° γ=90.00°
C14H18BNO5
C14H18BNO5
Dalton transactions (Cambridge, England : 2003) (2015) 44, 40 17600-17616
a=5.3490(6)Å b=14.2059(17)Å c=19.214(2)Å
α=90.00° β=90.00° γ=90.00°
C16H25Cl3N2O5
C16H25Cl3N2O5
Organic letters (2012) 14, 4 1082-1085
a=11.567(3)Å b=6.2104(14)Å c=15.200(3)Å
α=90.00° β=105.426(3)° γ=90.00°
C16H25Cl3N2O5
C16H25Cl3N2O5
Organic letters (2012) 14, 4 1082-1085
a=11.210(6)Å b=18.823(9)Å c=20.925(10)Å
α=90.00° β=90.00° γ=90.00°
<i>tert</i>-Butyl 4'-(4-bromophenyl)-1''-methyl-2,2''-dioxo-5'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-1-carboxylate
C36H31BrN2O5
Acta Crystallographica Section C (2015) 71, 8
a=9.5268(12)Å b=13.0566(17)Å c=13.4593(17)Å
α=94.401(2)° β=97.385(2)° γ=107.762(2)°